论文部分内容阅读
目的观察普米克令舒联合可必特雾化吸入治疗儿童喘息性疾病的疗效。方法将250例儿童喘息性疾病患儿随机分为两组,治疗组应用普米克令舒联合可必特雾化吸入;对照组给予沙丁胺醇雾化吸入,比较两组疗效。结果治疗组总有效率为92.8%,对照组总有效率为70.4%,平均住院日明显缩短(P<0.05)。结论普米克令舒联合可必特雾化吸入治疗儿童喘息性疾病,不良反应小,方法安全、简便,疗效确切,易被患儿及家属接受。二者合用均未出现不良反应,值得临床应用。
Objective To observe the curative effect of pulmicort respules cobiblite inhalation on asthmatic children. Methods 250 children with asthmatic disease were randomly divided into two groups. The treatment group was treated with Pulmicort Respules combined with Kebite inhalation. The control group was treated with salbutamol inhalation. The curative effect was compared between the two groups. Results The total effective rate was 92.8% in the treatment group and 70.4% in the control group, and the average length of stay was significantly shorter (P <0.05). Conclusion Pulmicort respules combined with Kebite nebulized inhalation treatment of asthmatic children with asthma, the adverse reaction is small, the method is safe, simple, effective and easy to be accepted by children and their families. Both combined with no adverse reactions, it is worth clinical application.